EUVIMEDEUVIMED entdecken
Crossref

Alu‐Mediated Deletion of FANCA in Turkish Families With Fanconi Anemia: Evidence of a Founder Effect

Ceren Damla Durmaz iD, Fatma Gümrük, Tiraje Celkan, Sule Unal, Arda Çetinkaya

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.63945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Ceren Damla Durmaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Fanconi Anemia, Fanconi Anemia Complementation Group A Protein, Alu Elements, Founder Effect. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Turkish Society of Pediatric Hematology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fanconi anemia (FA) is a rare inherited bone marrow failure syndrome characterized by pancytopenia, increased susceptibility to malignancies, and a spectrum of congenital anomalies. Here, we report on eight affected individuals from six unrelated families with a large Alu‐mediated intragenic deletion encompassing exons 6–31 in the FANCA gene, identified as a founder mutation in the Turkish population through haplotype analysis. This deletion, mediated by Alu repeat sequences, underscores the role of repetitive elements in FA pathogenesis. Clinical data revealed variable phenotypic presentations among affected individuals, highlighting the challenge of establishing genotype–phenotype correlations even in the presence of identical FANCA pathogenic variants. We carried out an easy and effective PCR‐based diagnostic test for detecting this mutation, enabling precise diagnosis and genetic counseling for affected individuals and their families. This study provides valuable insights into the molecular mechanisms underlying FA pathogenesis and offers a practical approach for genetic diagnosis in affected individuals, particularly those of Turkish descent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fanconi AnemiaFanconi Anemia Complementation Group A ProteinAlu ElementsFounder EffectSequence DeletionHumansTurkeyMaleFemalePedigreeChildChild, PreschoolHaplotypesAdultGenetic Association StudiesAdolescentExonsPhenotype

Stichwörter der Autor:innen

FANCAAlu repeatsFanconi anemiafounder effecthaplotype analysisintragenic deletion

Substanzen

Fanconi Anemia Complementation Group A ProteinFANCA protein, human

Autor:innen und Institutionen

  • Department of Medical Genetics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Department of Pediatric Hematology, Research Center for Fanconi Anemia and Other Inherited Bone Marrow Failure Syndromes, Hacettepe University, Ankara, Turkey.
  • Department of Pediatric Hematology Oncology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

ORCID-Profile: Ceren Damla Durmaz

Förderung

  • Turkish Society of Pediatric Hematology

Zitieren

APA

Durmaz, C. D., Gümrük, F., Celkan, T., Unal, S., & Çetinkaya, A. (2025). Alu‐Mediated Deletion of FANCA in Turkish Families With Fanconi Anemia: Evidence of a Founder Effect. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63945

Vancouver

Durmaz CD, Gümrük F, Celkan T, Unal S, Çetinkaya A. Alu‐Mediated Deletion of FANCA in Turkish Families With Fanconi Anemia: Evidence of a Founder Effect. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63945

BibTeX
@article{Durmaz2025,
  author = {Durmaz, Ceren Damla and Gümrük, Fatma and Celkan, Tiraje and Unal, Sule and Çetinkaya, Arda},
  title = {Alu‐Mediated Deletion of FANCA in Turkish Families With Fanconi Anemia: Evidence of a Founder Effect},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.63945}
}
Kostenlos starten →